Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH MDS 2021 | MDS biology: somatic mutations, the microenvironment & inflammation

Shahram Kordasti • 27 Jan 2021
ESH MDS 2021
Myelodysplastic Syndromes

Shahram Kordasti, MD, PhD, King’s College London, London, UK, discusses the core biology of myelodysplastic syndromes (MDS), highlighting the impact of somatic mutations and the microenvironment on disease outcomes. In addition to this, Dr Kordasti outlines the impact of chronic inflammation, detailing how activation of the inflammasome pathway contributes to the expansion of malignant clones and genomic instability. This interview took place during the 2021 European School of Hematology (ESH) 7th Translational Research E-Conference on Myelodysplastic Syndromes.

More from Shahram Kordasti

2:06
Understanding the role of inflammation and the immunome in MDS pathophysiology
Shahram Kordasti • 5 Apr 2024
2:53
Immune checkpoint inhibitors in MDS: the i4MDS consortium
Shahram Kordasti • 5 Apr 2024
4:27
The role of immune checkpoint inhibitors in MDS
Shahram Kordasti • 22 Sep 2021
6:05
The immune system's role in higher-risk MDS
Shahram Kordasti • 22 Sep 2021

Related Videos

2:22
Haplo-SCT for older patients with AML/MDS, and should age be a barrier to transplantation?
Raynier Devillier • 15 Apr 2024
2:31
Emerging treatment options for patients with ESA-refractory MDS: luspatercept & imetelstat
Eva Hellström-Lindberg • 11 Apr 2024
1:49
The unmet needs of patients with VEXAS syndrome
Maël Heiblig • 17 Apr 2024
1:25
The role of the bone marrow microenvironment in hematological malignancies
Manja Wobus • 17 Apr 2024
The content of VJHemOnc is intended for healthcare professionals